Spots Global Cancer Trial Database for radiotherapy (rt)
Every month we try and update this database with for radiotherapy (rt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparison of Different Subsequent Treatments After Radical Surgery | NCT00806117 | Cervical Cancer | Radiotherapy (R... Concurrent chem... Sequence chemot... | 18 Years - 65 Years | Sun Yat-sen University | |
| Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute | NCT02655744 | Primary Central... | Standard treatm... | 18 Years - 84 Years | Chang Gung Memorial Hospital | |
| Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer | NCT04394325 | Breast Cancer | Digital informa... | 18 Years - | Jonkoping University | |
| A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA | NCT02363400 | Nasopharyngeal ... | MEP | 20 Years - | National Health Research Institutes, Taiwan | |
| Digi-Do - a Digital Information Tool to Help Patients Diagnosed With Breast Cancer | NCT04394325 | Breast Cancer | Digital informa... | 18 Years - | Jonkoping University | |
| Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer | NCT06391034 | Prostate Cancer | hyperpolarized ... Non-investigati... Radiotherapy (R... Multi-parametri... Non-interventio... Prostate Biopsy | 18 Years - | University of California, San Francisco | |
| Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01154920 | Head and Neck S... | Paclitaxel Carboplatin Cetuximab Docetaxel Cisplatin Fluorouracil Radiotherapy (R... Chemotherapy | 18 Years - | M.D. Anderson Cancer Center | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA) | NCT05267158 | Brain Metastase... Brain Neoplasms... | 18 Years - | UMC Utrecht | ||
| Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | NCT03770689 | Locally Advance... | Peposertib 50 m... Peposertib 100 ... Peposertib 150 ... Peposertib 250 ... Capecitabine Radiotherapy (R... | 18 Years - | EMD Serono | |
| The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA) | NCT05267158 | Brain Metastase... Brain Neoplasms... | 18 Years - | UMC Utrecht | ||
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer | NCT03122509 | Metastatic Colo... | durvalumab tremelimumab Radiotherapy (R... ablation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Skin Cancer and Hyperthermia and Radiotherapy | NCT06384053 | Basal Cell Carc... Squamous Cell C... Non-melanoma Sk... | Water-filtered ... Radiotherapy (R... | 65 Years - | Kantonsspital Winterthur KSW | |
| Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00002774 | Squamous Neck C... | Tirapazamine Cisplatin 5-fluorouracil Radiotherapy (R... | 17 Years - | Stanford University | |
| Comparison of Different Subsequent Treatments After Radical Surgery | NCT00806117 | Cervical Cancer | Radiotherapy (R... Concurrent chem... Sequence chemot... | 18 Years - 65 Years | Sun Yat-sen University | |
| The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA) | NCT05267158 | Brain Metastase... Brain Neoplasms... | 18 Years - | UMC Utrecht | ||
| Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer | NCT03770689 | Locally Advance... | Peposertib 50 m... Peposertib 100 ... Peposertib 150 ... Peposertib 250 ... Capecitabine Radiotherapy (R... | 18 Years - | EMD Serono | |
| Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer | NCT06391034 | Prostate Cancer | hyperpolarized ... Non-investigati... Radiotherapy (R... Multi-parametri... Non-interventio... Prostate Biopsy | 18 Years - | University of California, San Francisco | |
| Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute | NCT02655744 | Primary Central... | Standard treatm... | 18 Years - 84 Years | Chang Gung Memorial Hospital | |
| REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors | NCT03317327 | Head and Neck S... | Nivolumab Radiotherapy (R... | 18 Years - | Oslo University Hospital | |
| Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer | NCT03715946 | Carcinoma, Squa... Oropharynx Squa... | Nivolumab Injec... Radiotherapy (R... | 18 Years - | University of Pittsburgh | |
| Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer | NCT06391034 | Prostate Cancer | hyperpolarized ... Non-investigati... Radiotherapy (R... Multi-parametri... Non-interventio... Prostate Biopsy | 18 Years - | University of California, San Francisco | |
| Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer | NCT06391034 | Prostate Cancer | hyperpolarized ... Non-investigati... Radiotherapy (R... Multi-parametri... Non-interventio... Prostate Biopsy | 18 Years - | University of California, San Francisco |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
